Chronic kidney disease (CKD) is frequently accompanied by hyperphosphatemia. High
serum phosphate usually requires dietary measures, adequate dialysis prescription and/or …

Hyperphosphatemia eventually develops in almost all patients with advanced chronic
kidney disease and is associated with negative clinical outcomes. Thus, guidelines …

Simple Summary Phosphate toxicity, the accumulation of toxic levels of phosphate in the
body, is associated with tumor growth and bone mineral abnormalities. Based on shared …

Objectives To assess whether medication beliefs differ between women who use or not use
medication for their somatic chronic diseases during pregnancy and whether this …

Background Adherence to treatment recommendations is challenging in hemodialysis (HD)
patients, yet it has been found to be extremely crucial in obtaining positive clinical and …

The treatment and interdisciplinary management of patients with chronic kidney disease
(CKD) continue to improve long-term outcomes. The medical nutrition intervention's role is to …

Background: Chronic kidney disease mineral and bone disorder (CKD-MBD) is an important
cause of morbidity, cardiovascular risk and mortality among patients with chronic kidney …

Abnormal serum phosphorus is a concern for adults undergoing dialysis due to the risk for
mortality and morbidity. General recommendations for maintaining serum phosphorus within …

Background Hyperphosphatemia poses a significant risk for cardiovascular diseases and
mortality in hemodialysis patients. Non-adherence to phosphate binders and a low …

Background Patients on hemodialysis (HD) often uses several medications, making them
highly susceptible to medication-related problems (MRP) thereby leading to medication …